1 day ago · Get Johnson & Johnson (JNJ.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the...

1 day ago · JNJ | Complete Johnson & Johnson stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Get the latest Johnson & Johnson (JNJ) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

3 days ago · Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the medicines of tomorrow.

Johnson & Johnson's stock symbol is JNJ and currently trades under NYSE. It’s current price per share is approximately $162.81. What are your Johnson & Johnson (JNJ) stock predictions? 22 Wall...

Johnson & Johnson's market capitalization is $346.63 B by 2.41 B shares outstanding. Is Johnson & Johnson stock a Buy, Sell or Hold? Johnson & Johnson stock has received a consensus rating of buy....

Real-time Price Updates for Johnson & Johnson (JNJ-N), along with buy or sell indicators, analysis, charts, historical performance, news and more

Jun 30, 2018 · Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9% ...

View the latest Johnson & Johnson (JNJ) stock price, news, historical charts, analyst ratings and financial information from WSJ.